LT - COMBINATIONS OF INHIBITORS OF MEK, EGFR AND ERBB2 IN THE TREATMENT OF KRAS-MUTANT LUNG CANCER
EN - COMBINATIONS OF INHIBITORS OF MEK, EGFR AND ERBB2 IN THE TREATMENT OF KRAS-MUTANT LUNG CANCER
Legal status
Patent not validated
Bibliographic data
Indications of the International Patent Classification (IPC)
(51) |
INT.CL. |
A61K 45/06 |
|
|
|
A61P 35/00 |
|
|
|
A61K 31/4184 |
|
|
|
A61K 31/517 |
|
|
|
A61K 31/5377 |
|
|
|
A61K 31/519 |
|
European patent
(11) |
Number of the document |
2968564 |
(13) |
Kind of document |
T |
(96) |
European patent application number |
14714409.1 |
|
Date of filing the European patent application |
2014-03-12 |
(97) |
Date of publication of the European application |
2016-01-20 |
(45) |
Date of publication and mention of the grant of the patent |
2019-05-08
|
(46) |
Date of publication of the claims translation |
|
PCT application
(86) |
Number |
PCT/NL2014/050148 |
|
Date |
2014-03-12 |
PCT application publication
(87) |
Number |
WO 2014/142660 |
|
Date |
2014-09-18 |
Priority applications
(30) |
Number |
Date |
Country code |
|
2010440 |
2013-03-12
|
NL |
Inventors
(72) |
SUN, Chong, NL
BERNARDS, Rene, NL
|
Grantee
(73) |
Stichting Het Nederlands Kanker Instituut- Antoni van Leeuwenhoek Ziekenhuis,
Plesmanlaan 121, 1066 CX Amsterdam,
NL
|
Title
(54) |
COMBINATIONS OF INHIBITORS OF MEK, EGFR AND ERBB2 IN THE TREATMENT OF KRAS-MUTANT LUNG CANCER |
|
COMBINATIONS OF INHIBITORS OF MEK, EGFR AND ERBB2 IN THE TREATMENT OF KRAS-MUTANT LUNG CANCER |